An ileostomy is where the small bowel is diverted to the abdominal surface resulting in the formation of a stoma. An Ileostomy can be temporary or permanent and produces loose faeces. Some ileostomates can develop high output in the early postoperative stage. Most will resolve, some will require ongoing treatment and management. While patients are monitored closely according to protocol in hospital once discharged into the community, there appears to be little standardisation. A literature search revealed that existing guidelines are for management of patients in the acute care setting. However, if not adequately prepared and monitored, patients with prolonged high output are at risk of complications including dehydration, acute kidney injury and malnutrition. This article discusses the development of a guideline aimed at improving education, monitoring and ultimately improving outcomes for patients with high-output stomas in the community.

Between 30% and 40% of patients diagnosed with colorectal cancer go on to have adjuvant chemotherapy. Although patients have a dedicated oncology team throughout their chemotherapy, they often look to their stoma care nurse for advice on peristomal skin complications. Therefore, stoma care nurses require knowledge and understanding of the actions of chemotherapy and its potential effects on skin health. This article aims to prompt discussion and improve awareness of the impact of chemotherapy on skin health in relation to stoma care. This overview of commonly used chemotherapy drugs is intended to develop an improved understanding of the types available, their pharmacological action and their implications for skin health.